Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Virology

• Publication date

  2001-06-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.2001.0945PMID 11414801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective T-Cell-Based Immunity Induced in Neonatal Mice by a Single Replicative Cycle of Herpes Simplex Virus

  2001cited by this paper
• Neonatal and early life vaccinology.

  2001cited by this paper
• Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.

  2000cited by this paper
• Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

  2000cited by this paper
• DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.

  2000cited by this paper
• Protective Immunity in Macaques Vaccinated with a Modified Vaccinia Virus Ankara-Based Measles Virus Vaccine in the Presence of Passively Acquired Antibodies

  2000influential reference
• Successful Vaccine-Induced Seroconversion by Single-Dose Immunization in the Presence of Measles Virus-Specific Maternal Antibodies

  2000cited by this paper
• Human Parainfluenza Virus Type 3 (PIV3) Expressing the Hemagglutinin Protein of Measles Virus Provides a Potential Method for Immunization against Measles Virus and PIV3 in Early Infancy

  2000cited by this paper
• Use of cotton rats for preclinical evaluation of measles vaccines.

  2000cited by this paper
• Vaccination in the Neonatal Period and Early Infancy

  2000cited by this paper
• Measles vaccines—A positive step toward eradicating a negative strand

  2000influential reference
• IFN-α and IL-12 Induce IL-18 Receptor Gene Expression in Human NK and T Cells1

  2000cited by this paper
• Measles vaccines, new developments and immunization strategies.

  1999cited by this paper
• IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants.

  1999influential reference
• Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies.

  1999cited by this paper
• Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.

  1999cited by this paper
• T-cell function in newborn mice and humans.

  1999cited by this paper
• Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice

  1999cited by this paper
• Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents.

  1998cited by this paper
• Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime‐boost strategies in mice

  1998cited by this paper
• Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?

  1998cited by this paper
• Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

  1998influential reference
• DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life.

  1997cited by this paper
• Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.

  1997cited by this paper
• Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains

  1996cited by this paper
• Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2‐biased pattern which persists after adult boosting

  1996cited by this paper
• Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria

  1996cited by this paper
• Antigenic analysis of current wild type and vaccine strains of measles virus.

  1995cited by this paper
• Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.

  1995cited by this paper
• Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

  1995cited by this paper
• Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.

  1992influential reference
• NYVAC: a highly attenuated strain of vaccinia virus.

  1992influential reference
• Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.

  1992cited by this paper
• Child mortality after high-titre measles vaccines: prospective study in Senegal.

  1991cited by this paper
• The complete DNA sequence of vaccinia virus.

  1990cited by this paper
• Cloning and expression of foreign genes in vaccinia virus, using a host range selection system

  1989cited by this paper
• Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses

  1988cited by this paper
• Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

  1985cited by this paper
• Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.

  1977cited by this paper

• T cells in the brain enhance neonatal mortality during peripheral LCMV infection.

  2021cites this paper
• Beyond vaccine dosage, genetic modifications to the current measles vaccine to overcome maternal passive immunity

  2018cites this paper
• Interferon regulatory factor 1 (IRF-1) directs IL-4/IL-13 induced death of neonatal Th1 cells

  2017cites this paper
• The Evolution of Poxvirus Vaccines

  2015cites this paper
• Maternal vaccination: moving the science forward.

  2015cites this paper
• Immunization of pregnant women: Future of early infant protection

  2015cites this paper
• Characterization of alphavirus replicon particle based vaccines and adjuvants in a neonatal murine model

  2014cites this paper
• In Vivo Expression of Recombinant Pregnancy‐Specific Glycoprotein 1a Inhibits the Symptoms of Collagen‐Induced Arthritis

  2014cites this paper
• The Role of Pregnancy‐Specific Glycoprotein 1a (PSG1a) in Regulating the Innate and Adaptive Immune Response

  2013cites this paper
• The neonatal immune system: immunomodulation of infections in early life

  2012cites this paper
• Regulation of Th2 Responses and Allergic Inflammation through Bystander Activation of CD8+ T Lymphocytes in Early Life

  2010cites this paper
• Yersinia enterocolitica Promotes Robust Mucosal Inflammatory T-Cell Immunity in Murine Neonates

  2010cites this paper
• Long-Lasting Protective Antiviral Immunity Induced by Passive Immunotherapies Requires both Neutralizing and Effector Functions of the Administered Monoclonal Antibody

  2010cites this paper
• Novel Strategies for Immunizing Infants in Developing Countries Who Are Too Young to Receive the Currently Licensed Measles Vaccines

  2009cites this paper
• Innate and Adaptive Immunity in Murine Neonates Infected with the Intestinal Pathogen Yersinia enterocolitica

  2009cites this paper
• Immune adjuvants in early life: targeting the innate immune system to overcome impaired adaptive response.

  2009cites this paper
• Murine neonatal recent thymic emigrants are phenotypically and functionally distinct from adult recent thymic emigrants.

  2009cites this paper
• Stabilising peptides of a sequential epitope of the Measles Virus Haemagglutinin protein and the implications for antigenicity and immunogenicity

  2009cites this paper
• Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo

  2008cites this paper
• Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit

  2008cites this paper
• Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens.

  2008cites this paper
• Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection.

  2006cites this paper
• Analysis of antigen handling by epidermal Langerhans' cells during the early neonatal period

  2004cites this paper
• Autocrine IL‐10 partially prevents differentiation of neonatal dendritic epidermal leukocytes into Langerhans cells

  2004cites this paper
• Neonatal adaptive immunity comes of age

  2004cites this paper
• Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells.

  2003cites this paper
• Virus de la vaccine ankara modifiee pour la vaccination des nouveau-nes

  2003cites this paper
• In vivo expression of recombinant pregnancy‐specific glycoprotein 1a induces alternative activation of monocytes and enhances Th2‐type immune response

  2003cites this paper
• CD 4-Independent Protective Cytotoxic T Cells Induced in Early Life by a Non-Replicative Delivery System Based on Virus-like Particles

  2003cites this paper
• CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles.

  2003cites this paper
• Experimental vaccines against measles in a world of changing epidemiology.

  2003cites this paper
• Viral Challenge in Mice Primed as Neonates Enhanced Type 1 Immunity After Secondary

  2002cites this paper
• Enhanced Type 1 Immunity After Secondary Viral Challenge in Mice Primed as Neonates1

  2002cites this paper
• Vaccination against measles: a neverending story

  2002cites this paper